Bethany Edouard, PA
Physician Assistant · Cape Coral, FLNPI 1881963106
Payments from drug & device makers
Across 458 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Novo Nordisk$846
- Amgen$746
- Merck$724
- Lilly USA, LLC$541
- Pfizer$466
- plus $4K from 45 others
What the payments were for
- Food & beverage$8,24498%
- Education$1752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,419 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $113,409 |
| EliquisApixaban | 63 | $77,451 |
| MounjaroTirzepatide | 62 | $70,246 |
| NuplazidPimavanserin Tartrate | 12 | $59,317 |
| XareltoRivaroxaban | 28 | $42,371 |
| JardianceEmpagliflozin | 30 | $34,222 |
| FarxigaDapagliflozin Propanediol | 28 | $29,475 |
| JanuviaSitagliptin Phosphate | 24 | $24,257 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $19,006 |
| MyrbetriqMirabegron | 20 | $17,366 |
| Repatha SureclickEvolocumab | 15 | $17,208 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 19 | $12,974 |
| JanumetSitagliptin Phos/Metformin Hcl | 18 | $12,299 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $10,310 |
| SynthroidLevothyroxine Sodium | 57 | $5,081 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $846 | $113,40994 claims |
| PfizerEliquis, Paxlovid | $466 | $80,33579 claims |
| Lilly USA, LLCMounjaro | $541 | $70,24662 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $187 | $47,19649 claims |
| Johnson & JohnsonXarelto | $387 | $42,37128 claims |
| MerckJanuvia, Janumet | $724 | $36,55742 claims |
| AstraZenecaFarxiga | $60 | $29,47528 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $1,005 | $29,31635 claims |
| Astellas Pharma US IncMyrbetriq | $381 | $17,36620 claims |
| AbbVieSynthroid | $385 | $5,08157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Cape Coral
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.